Table 4.
Multivariate analysis.
| UNIVARIATE (n = 84) | MULTIVARIATE (n = 84) | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p-Value | HR | 95% CI | p-Value | |
| Metabolomic risk (High vs. Low) |
3.68 | 1.65–8.22 | 0.001 | 3.18 | 1.41–7.15 | 0.005 |
| Stage (III vs. I–II) |
3.57 | 1.51–8.46 | 0.004 | 3.05 | 1.28–7.28 | 0.012 |
| Histologic grade (G3 vs. G1–G2) |
1.71 | 0.72–4.04 | 0.2 | |||
| Cancer localization (Right vs. Left/Rectum) |
0.97 | 0.45–2.08 | > 0.9 | |||
| Adjuvant chemotherapy (No vs. Yes) |
0.53 | 0.21–1.31 | 0.2 | |||
| Tumor dimension (T3–T4 vs. T1–T2) |
2.34 | 0.32–17.3 | 0.4 | |||
HR = Hazard Ratio, CI = confidence interval criteria for entry and stay in the multivariate model is p < 0.05. N patients with complete data for selected covariates n = 84.